Vincent Vultaggio A's most recent trade in Zentalis Pharmaceuticals Inc was a trade of 158,586 Common Stock done . Disclosure was reported to the exchange on Feb. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals Inc | Vincent Vultaggio A | PAO and Interim PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 158,586 | 192,441 | - | 0 | Common Stock | |
| Zentalis Pharmaceuticals Inc | Vincent Vultaggio A | PAO and Interim PFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 35,633 | 35,633 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharmaceuticals Inc | Vincent Vultaggio A | PAO and Interim PFO | Sale of securities on an exchange or to another person at price $ 1.71 per share. | 03 Feb 2025 | 2,615 | 189,826 | - | 1.7 | 4,476 | Common Stock |